HEPATOCELLULAR CARCINOMA RECURRENT
Clinical trials for HEPATOCELLULAR CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver transplant patients with returning cancer: drug combo under study
Disease control Recruiting nowThis study is for liver transplant patients whose liver cancer has come back and cannot be treated with surgery or local therapies. Researchers want to see if a combination of two drugs, Atezolizumab and Bevacizumab, is safe when given with a special plan to prevent organ rejecti…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New device offers hope for advanced liver cancer patients with no options left
Disease control Recruiting nowThis study is for people with advanced liver cancer that has come back or spread, and who have already tried at least two standard treatments without success. The goal is to see if using a device called TheraBionic P1 can help them live longer and improve their quality of life. P…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 26, 2026 12:06 UTC